Subscribe To
BVNRY / Bavarian Nordic raises sales guidance after monkeypox vaccine order
BVNRY News
By Reuters
May 18, 2023
People at high risk to mpox should get 2 doses of Bavarian Nordic vaccine, US CDC says
The U.S. Centers for Disease Control and Prevention is urging people at high risk of mpox to get two doses of Bavarian Nordic's Jynneos vaccine, based more_horizontal
By Seeking Alpha
May 14, 2023
Bavarian Nordic A/S (BVNKF) Q1 2023 Earnings Call Transcript
Call Start: 08:00 January 1, 0000 8:50 AM ET Bavarian Nordic A/S (OTCPK:BVNKF) Q1 2023 Earnings Conference Call May 9, 2023 08:00 ET Company Participa more_horizontal
By CNBC
April 25, 2023
Mpox outbreak was wake-up call for smallpox preparation, vaccine maker Bavarian Nordic says
Bavarian Nordic plans to sharply scale up production of its Jynneos vaccine to prepare for a smallpox emergency, CEO Paul Chaplin said. more_horizontal
By Seeking Alpha
November 12, 2022
Bavarian Nordic A/S (BVNKF) Q3 2022 Earnings Call Transcript
Bavarian Nordic A/S (OTCPK:BVNKF) Q3 2022 Results Conference Call November 9, 2022 8:00 AM ET Company Participants Rolf Sorensen - Investor Relations more_horizontal
By Seeking Alpha
September 11, 2022
Bavarian Nordic A/S Could Post A Strong Comeback
Bearish sentiment weighed heavily on the biotech industry and Bavarian Nordic A/S. There is reason for optimism given the current opportunities offere more_horizontal
By InvestorPlace
August 24, 2022
BVNRY Stock Alert: What to Know as Bavarian Nordic Signs Supply Agreement
Source: angellodeco / Shutterstock.com Bavarian Nordic (OTCMKTS: BVNRY ) stock is on the move Wednesday after the vaccine company signed a supply agre more_horizontal
By Barrons
July 26, 2022
4 Things to Know About Company Making the Monkeypox Vaccine
The Centers for Disease Control and Prevention has reported 3,487 monkeypox cases in the U.S. so far. more_horizontal
By Market Watch
July 15, 2022
Bavarian Nordic stock jumps after U.S. orders 2.5 million more monkeypox vaccine doses
The U.S.-listed shares of Bavarian Nordic A/S BVNRY, +3.87% BAVA, +0.56% jumped 2.0% in afternoon trading Friday, after the Denmark-based drug maker s more_horizontal